Neuroleptic Malignant Syndrome After Re-introduction of Atypical Antipsychotics in a COVID-19 Patient

We present a case of neuroleptic malignant syndrome (NMS) in a 46-year-old white female from a state psychiatric hospital who also tested positive for coronavirus-2019 (COVID-19) (severe acute respiratory syndrome coronavirus, SARS-CoV-2) infection after re-introduction of her home antipsychotics me...

Descripción completa

Detalles Bibliográficos
Autores principales: Espiridion, Eduardo D, Mani, Valli, Oladunjoye, Adeolu O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980951/
https://www.ncbi.nlm.nih.gov/pubmed/33763319
http://dx.doi.org/10.7759/cureus.13428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980951/
https://www.ncbi.nlm.nih.gov/pubmed/33763319
http://dx.doi.org/10.7759/cureus.13428

Ejemplares similares